[{"Assets_0_Q2_USD":"10097307000.0","CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"32.59","EarningsPerShareBasic_2_Q2_USD":"55.52","EarningsPerShareDiluted_1_Q2_USD":"32.15","EarningsPerShareDiluted_2_Q2_USD":"54.84","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"154930000.0","NetIncomeLoss_1_Q2_USD":"966429000.0","NetIncomeLoss_2_Q2_USD":"1652341000.0","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q2_USD":"536880000.0","RevenuesConverted_2_Q2_USD":"1108524000.0","SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q2_USD":"7353402000.0","Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"30058000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"30131000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"29652000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"29759000.0","filed":"20200731","footnote":null,"form":"10-Q","fp":"Q2","fy":"2020.0","name":"BIO-RAD LABORATORIES, INC.","period":"20200630","qtrs":"1","uom":"USD"}]